Trichodermin shows potent anti-glioblastoma effects, enhancing temozolomide efficacy
Trichodermin exhibits significant anti-glioblastoma activity by inducing cell cycle arrest and apoptosis, while also enhancing the efficacy of temozolomide.
Asset / Drug
Drug and asset intelligence for Trichodermin with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.